Genfit SA (GNFT)
4.535
-0.68
(-12.96%)
USD |
NASDAQ |
Nov 14, 16:00
4.535
0.00 (0.00%)
After-Hours: 20:00
Genfit Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Edap TMS SA | 1.887M |
Cellectis SA | 23.83M |
Ascendis Pharma AS | 89.88M |
Adaptimmune Therapeutics PLC | 40.45M |
Akari Therapeutics PLC | 3.314M |